Jennison Associates cuts position in AmSurg by 14%: 5 things to know

Jennison Associates reduced its stake in AmSurg by 14 percent during the fourth quarter, according to a report by The Vista Voice.

Advertisement

Here are five things to know:

1. Jennison Associates sold 184,423 shares of AmSurg stock.

2. The stock’s 50-day moving average price is $74.51 and its 200-day moving average price is $75.12.

3. AmSurg has a one-year low of $54.11 and a one-year high of $87.42.

4. The firm has a market cap of $4.22 billion.

5. AmSurg has an average rating of “buy” and a consensus target price of $91 from all analysts covering the stock.

More articles on surgery centers:
RMC Medstone sells majority interest in Stanislaus Surgical Hospital: 5 key notes
Sanderson Farms CEO donates $10M for University of Mississippi Medical Center pediatric expansion, includes outpatient clinic — 5 notes
UF Health opens $11M pediatric ASC: 4 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.